Enliven Therapeutics, Inc.

ELVN · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$124,117$100,141$75,536$110,024
Short-Term Investments$189,323$153,007$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$4,687$13,003$2,217$646
Total Curr. Assets$318,127$266,151$77,753$110,670
Property Plant & Equip (Net)$458$1,062$1,516$954
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$54$0
Tax Assets$0$0$0$0
Other NC Assets$7,175$4,654$3,975$1,705
Total NC Assets$7,633$5,716$5,545$2,659
Other Assets$0$0$0$0
Total Assets$325,760$271,867$83,298$113,329
Liabilities
Payables$1,342$532$3,438$2,521
Short-Term Debt$0$335$323$159
Tax Payable$0$0$0$0
Deferred Revenue$0$0$5,507$0
Other Curr. Liab.$14,573$25,027$447$3,073
Total Curr. Liab.$15,915$25,894$9,715$5,753
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$67$150,408$714
Total NC Liab.$0$67$150,408$714
Other Liabilities$0$0$0$0
Cap. Leases$0$335$323$159
Total Liabilities$15,915$25,961$160,123$6,467
Equity
Pref Stock$0$0$150$149,749
Common Stock$49$41$1$1
Retained Earnings-$243,472-$154,448-$82,864-$45,202
AOCI$55$141-$150$0
Other Equity$553,213$400,172$6,038$2,314
Total Equity$309,845$245,906-$76,825$106,862
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$325,760$271,867$83,298$113,329
Net Debt-$124,117-$99,806-$75,213-$109,865
Enliven Therapeutics, Inc. (ELVN) Financial Statements & Key Stats | AlphaPilot